Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Jaundice
ADR ID BADD_A02422
ADR Hierarchy
01      Blood and lymphatic system disorders
01.06      Haemolyses and related conditions
01.06.04      Haemolyses NEC
01.06.04.004      Jaundice
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.01      Cholestasis and jaundice
09.01.01.004      Jaundice
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.03      Dermal and epidermal conditions NEC
23.03.03.030      Jaundice
Description A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction. [MeSH]
MedDRA Code 10023126
MeSH ID D007565
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Icterus | Jaundice | Jaundice (excl neonatal) | Jaundice NOS | Jaundice, unspecified, not of newborn | Subicteric | Jaundice, Hemolytic | Hemolytic Jaundice | Hemolytic Jaundices | Jaundices, Hemolytic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01942Riluzole0.000538%
BADD_D01951Risperidone0.000994%
BADD_D01952Ritonavir0.000735%
BADD_D01954Rivaroxaban--
BADD_D01955Rivastigmine--
BADD_D01961Rofecoxib--
BADD_D01968Ropivacaine hydrochloride--
BADD_D01969Ropivacaine hydrochloride monohydrate--
BADD_D01970Rosiglitazone maleate--
BADD_D01971Rosuvastatin0.000115%
BADD_D01972Rosuvastatin calcium--
BADD_D01975Roxithromycin--
BADD_D01987Sapropterin0.004312%
BADD_D01989Saquinavir mesylate--
BADD_D02010Sertraline0.000115%
BADD_D02011Sertraline hydrochloride--
BADD_D02015Sevoflurane--
BADD_D02020Silodosin--
BADD_D02026Simvastatin0.000065%
BADD_D02029Sitagliptin0.000318%
BADD_D02031Sitaxentan--
BADD_D02033Sodium aurothiomalate--
BADD_D02053Sofosbuvir0.005702%
BADD_D02058Sorafenib0.003537%
BADD_D02062Sparfloxacin--
BADD_D02066Spironolactone0.000146%
BADD_D02068Stavudine--
BADD_D02093Sulfasalazine0.001121%
BADD_D02097Sulindac--
BADD_D02100Sunitinib0.004007%
The 16th Page    First    Pre   16 17 18 19    Next   Last    Total 19 Pages
ADReCS-Target
ADR Term Drug Name Target